Cargando…

OLFML2A is necessary for anti-triple negative breast cancer effect of selective activator protein‐1 inhibitor T-5224

Previous studies have shown that expression of activator protein-1 (AP-1) family is significantly elevated in triple-negative breast cancer (TNBC), compared with that in other breast cancer subtypes. Here we investigated the anti-tumor effect and mechanism of T-5224, an inhibitor of c-Fos/AP-1, on T...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Qian, Zhang, Kaixin, Li, Yong, Ren, Yaxuan, Shi, Jikang, Gu, Yulu, Qiu, Shuang, Liu, Sainan, Cheng, Yi, Qiao, Yichun, Liu, Yawen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Neoplasia Press 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8138778/ https://www.ncbi.nlm.nih.gov/pubmed/33993098 http://dx.doi.org/10.1016/j.tranon.2021.101100

Ejemplares similares

Down-regulated FST expression is involved in the poor prognosis of triple-negative breast cancer
por: Liu, Sainan, et al.
Publicado: (2021)

Epidemiological status quo of hypertension in elderly population in Changchun, China: a cross-sectional study
por: Ren, Yaxuan, et al.
Publicado: (2022)

Association between ATM rs1801516 polymorphism and cancer susceptibility: a meta-analysis involving 12,879 cases and 18,054 controls
por: Gu, Yulu, et al.
Publicado: (2018)

ε2 allele and ε2-involved genotypes (ε2/ε2, ε2/ε3, and ε2/ε4) may confer the association of APOE genetic polymorphism with risks of nephropathy in type 2 diabetes: a meta-analysis
por: Shi, Jikang, et al.
Publicado: (2020)

Selective activator protein‐1 inhibitor T‐5224 prevents lymph node metastasis in an oral cancer model
por: Kamide, Daisuke, et al.
Publicado: (2016)

Olfactomedin-like 2 A and B (OLFML2A and OLFML2B) expression profile in primates (human and baboon)
por: Pérez-Ibave, Diana Cristina, et al.
Publicado: (2016)

Social-biological influences on sleep duration among adult residents of Northeastern China
por: Ren, Yaxuan, et al.
Publicado: (2019)

T5224, RSPO2 and AZD5363 are novel drugs against functional pituitary adenoma
por: Zhong, Sheng, et al.
Publicado: (2019)

OLFML2A Downregulation Inhibits Glioma Proliferation Through Suppression of Wnt/β-Catenin Signaling
por: Ma, Shize, et al.
Publicado: (2021)

OLFML2A Overexpression Predicts an Unfavorable Prognosis in Patients with AML
por: Lu, Xuan, et al.
Publicado: (2023)

Pan-Cancer Analysis of OLFML2B Expression and Its Association With Prognosis and Immune Infiltration
por: Hu, Pengbo, et al.
Publicado: (2022)

Surfaceome CRISPR screen identifies OLFML3 as a rhinovirus-inducible IFN antagonist
por: Mei, Hong, et al.
Publicado: (2021)

Bioinformatic exploration of OLFML2B overexpression in gastric cancer base on multiple analyzing tools
por: Liu, Jiaxin, et al.
Publicado: (2019)

Correction to: Bioinformatic exploration of OLFML2B overexpression in gastric cancer base on multiple analyzing tools
por: Liu, Jiaxin, et al.
Publicado: (2019)

Correction: Surfaceome CRISPR screen identifies OLFML3 as a rhinovirus-inducible IFN antagonist
por: Mei, Hong, et al.
Publicado: (2021)

Associations between three common single nucleotide polymorphisms (rs266729, rs2241766, and rs1501299) of ADIPOQ and cardiovascular disease: a meta-analysis
por: Kanu, Joseph Sam, et al.
Publicado: (2018)

OLFML3 Expression is Decreased during Prenatal Muscle Development and Regulated by MicroRNA-155 in Pigs
por: Zhao, Shuanping, et al.
Publicado: (2012)

GeneChip expression profiling identified OLFML2A as a potential therapeutic target in TNBC cells
por: Gao, Xiufei, et al.
Publicado: (2022)

Meta-analysis of the association between Apolipoprotein E polymorphism and risks of myocardial infarction
por: Shao, Aiyu, et al.
Publicado: (2022)

Addendum: Yang, Z., et al. Multi-Toxic Endpoints of the Foodborne Mycotoxins in Nematode Caenorhabditis elegans. Toxins (Basel), 2015, 7(12), 5224–5235
por: Yang, Zhendong, et al.
Publicado: (2016)

T-5224, a selective inhibitor of c-Fos/activator protein-1, improves survival by inhibiting serum high mobility group box-1 in lethal lipopolysaccharide-induced acute kidney injury model
por: Ishida, Mari, et al.
Publicado: (2015)

Microglia-Specific Expression of Olfml3 Is Directly Regulated by Transforming Growth Factor β1-Induced Smad2 Signaling
por: Neidert, Nicolas, et al.
Publicado: (2018)

Targeting OLFML3 in Colorectal Cancer Suppresses Tumor Growth and Angiogenesis, and Increases the Efficacy of Anti-PD1 Based Immunotherapy
por: Stalin, Jimmy, et al.
Publicado: (2021)

Association between eNOS rs1799983 polymorphism and hypertension: a meta-analysis involving 14,185 cases and 13,407 controls
por: Shi, Jikang, et al.
Publicado: (2021)

Nexus between genome-wide copy number variations and autism spectrum disorder in Northeast Han Chinese population
por: Qiu, Shuang, et al.
Publicado: (2023)

Association between MTHFR C677T/A1298C and susceptibility to autism spectrum disorders: a meta-analysis
por: Li, Yan, et al.
Publicado: (2020)

Arginine to Glutamine Variant in Olfactomedin Like 3 (OLFML3) Is a Candidate for Severe Goniodysgenesis and Glaucoma in the Border Collie Dog Breed
por: Pugh, Carys A., et al.
Publicado: (2019)

OLFML2B Is a Robust Prognostic Biomarker in Bladder Cancer Through Genome-Wide Screening: A Study Based on Seven Cohorts
por: Lin, Jiaxing, et al.
Publicado: (2021)

A cytoplasmic COMPASS is necessary for cell survival and triple-negative breast cancer pathogenesis by regulating metabolism
por: Wang, Lu, et al.
Publicado: (2017)

Advances in immunotherapy for triple-negative breast cancer
por: Liu, Yang, et al.
Publicado: (2023)

Correction: Advances in immunotherapy for triple-negative breast cancer
por: Liu, Yang, et al.
Publicado: (2023)

Is it necessary for young patients with recurrent implantation failure to undergo preimplantation genetic testing for aneuploidy?
por: Du, Yulin, et al.
Publicado: (2023)

New Perspectives for Resistance to PARP Inhibitors in Triple-Negative Breast Cancer
por: Han, Ye, et al.
Publicado: (2020)

Inhibition of CXorf56 promotes PARP inhibitor-induced cytotoxicity in triple-negative breast cancer
por: Zhu, Ying, et al.
Publicado: (2023)

Is triple artemisinin-based combination therapy necessary for uncomplicated malaria?
por: van der Pluijm, Rob W, et al.
Publicado: (2022)

Role of BET Inhibitors in Triple Negative Breast Cancers
por: Khandekar, Durga, et al.
Publicado: (2020)

HDAC Inhibitors for the Therapy of Triple Negative Breast Cancer
por: Maccallini, Cristina, et al.
Publicado: (2022)

Comparison of Clinicopathological Features and Prognosis in Triple-Negative and Non-Triple Negative Breast Cancer
por: Qiu, Jingdan, et al.
Publicado: (2016)

MicroRNA-645 targets urokinase plasminogen activator and decreases the invasive growth of MDA-MB-231 triple-negative breast cancer cells
por: Meng, Du, et al.
Publicado: (2018)

Nanoparticles for Chemoimmunotherapy Against Triple-Negative Breast Cancer
por: Liu, Siyan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4qq3kqnt4cpm0c8i1kngsonrte